Your session is about to expire
← Back to Search
Clavulanic Acid for Quitting Smoking
Study Summary
This trial is testing whether a drug called clavulanic acid can help people quit smoking.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am taking antidepressants that help with quitting smoking.I have not had electroconvulsive therapy in the last 6 months.I do not have disabilities that prevent me from completing health assessments.My kidney function tests are outside the normal range.I am between 18 and 65 years old.I agree not to use any tobacco or nicotine products during the study.I have had a head injury or a brain condition that shows up on MRI scans.I have provided a negative pregnancy test result.I have a serious illness that hasn't been treated yet.I haven't taken carbamazepine, nitroglycerin, or similar risky drugs with CLAV in the last 14 days.
- Group 1: Clav
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What ailment does Clav usually address?
"Clav can be used to fight off enterobacter cloacae, tonsillitis, and gonorrhoea."
How many individuals can join this research project?
"The listing on clinicaltrials.gov says that this study is open and recruiting patients right now. The trial was first posted on March 26th, 2019 with the most recent update being May 19th, 2022. So far, 30 people have been enrolled at the single site location."
Are there Clav any long-term side effects?
"Clav's safety is estimated to be a 2. As this is only a Phase 2 trial, there is data suggesting that Clav is safe, but not yet any evidence that it is effective."
Are there similar studies that have used Clav?
"There are a total of 21 studies currently underway for Clav. Out of these, 5 are in the critical Phase 3 stage. The majority of research centres conducting these studies are based in Chicago, Illinois; however, there are 394 locations running trials for Clav across the world."
Does this research project have an age limit?
"For this specific study, only patients aged 18 to 65 can apply. In contrast, there are 93 clinical trials for people under the age of 18 and 347 for patients over 65."
Are we looking for more participants in this experiment?
"That is correct. The listing on clinicaltrials.gov specifies that the research team is still looking for 30 subjects at a single study site. This trial was first posted on March 26th, 2019 and received its latest update on May 19th, 2020."
How can I sign up to be a part of this research opportunity?
"Up to 30 individuals that struggle with tobacco addiction and meet the age requirements of 18-65 years old can enroll in this trial. Key inclusion criteria for participants include: a willingness to abstain from all other nicotine products for the entirety of the study, functional vision, and meeting the age requirement."
Share this study with friends
Copy Link
Messenger